Arcus Biosciences (RCUS) Change in Acquisitions & Divestments (2017 - 2022)

Arcus Biosciences' Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $228.0 million for Q3 2022.

• In Q3 2022, Change in Acquisitions & Divestments rose 70.93% year-over-year to $228.0 million; the TTM figure through Sep 2022 stood at $608.8 million (down 18.19% YoY), while the FY2021 annual figure was $690.1 million, up 124.53% from the prior year.
• Change in Acquisitions & Divestments was $228.0 million for Q3 2022 at Arcus Biosciences, up from $169.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $251.4 million in Q1 2021 to a low of $25.6 million in Q1 2018.
• Historically, Change in Acquisitions & Divestments has averaged $102.6 million across 5 years, with a median of $87.3 million in 2019.
• The sharpest annual moves came in 2021 and 2022: Change in Acquisitions & Divestments soared 411.42% in 2021, then sank 62.68% in 2022.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $42.3 million in 2018, then jumped by 31.59% to $55.6 million in 2019, then surged by 209.42% to $172.0 million in 2020, then plunged by 31.45% to $117.9 million in 2021, then surged by 93.36% to $228.0 million in 2022.
• The last three Change in Acquisitions & Divestments figures came in at $228.0 million (Q3 2022), $169.0 million (Q2 2022), and $93.8 million (Q1 2022), per Business Quant data.